URL has been copied successfully!
Skip to content
JBizNews
JBizNews
Primary Navigation Menu
Menu
  • Home
  • Breaking News
  • Top News
  • Markets
  • Crypto
  • Health
  • Real Estate
  • Events
  • Subscribe
  • About JBizNews

Health

  • August 21, 2026

    Fitch explains how healthcare organizations can keep strong credit ratings despite cyberattacks


  • August 21, 2026

    STAT+: Are cancer patients getting too much drug?


  • August 21, 2026

    STAT+: Are cancer patients getting too much drug?


  • August 21, 2026

    STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more


  • August 21, 2026

    STAT+: Pharmalittle: We’re reading about a big Roche investment in the U.S., estrogen patch shortages, and more


  • August 21, 2026

    Scientists deploy Merck’s Ebola vaccine in DRC


  • August 21, 2026

    Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?


  • August 21, 2026

    Opinion: Lil Nas X’s bipolar diagnosis and the paradox of treatment


  • August 21, 2026

    Opinion: A cure for HIV would be a triumph. But it shouldn’t harm survivors


  • August 20, 2026

    Physician group sues Trump administration over dietary guidelines process 


  • August 20, 2026

    Humana taps physician executive as new chief medical officer


  • August 20, 2026

    R1 drills down on AI prior authorizations with Humata buy


  • August 20, 2026

    Trump nominates policy aide Overton to lead FDA


  • August 20, 2026

    Providence names new CFO amid financial turnaround


  • August 20, 2026

    STAT+: How a Trump loyalist got the FDA nomination


  • August 20, 2026

    STAT+: Pharmalittle: We’re reading about a Regeneron rare disease drug, an Ultragenyx gene therapy, and more


  • August 20, 2026

    Contrasting legal decisions on gender-affirming care


  • August 20, 2026

    STAT+: FDA approves Ultragenyx gene therapy


  • August 20, 2026

    STAT+: One of the most consequential years for cancer treatment, ever


  • August 20, 2026

    STAT+: Capricor Therapeutics’ Duchenne treatment is heading for an FDA rejection


  • August 20, 2026

    STAT+: How health systems are embracing chatbots to query and summarize patient records


  • August 20, 2026

    Opinion: Capricor’s Duchenne muscular dystrophy drug and the countless tiny decisions that can make or break a study


  • August 20, 2026

    Reduce protein to increase longevity? Nutrition experts say that’s a bad idea


  • August 20, 2026

    Can reclassifying muscle dysmorphia unlock better care for boys and men?


  • August 20, 2026

    Opinion: The global health aid architecture is collapsing. The faith economy isn’t


  • August 19, 2026

    STAT+: How Trump loyalist Heidi Overton became the president’s pick to run the FDA


  • August 19, 2026

    STAT+: New CDC director tells staff she is prepared to speak ‘truth to power’


  • August 19, 2026

    Ossoff Spotlights Natalie Harp: Cancer Survivor Who Credits Trump’s Right to Try Act Is Now His Trusted White House Operator


  • August 19, 2026

    STAT+: Regeneron drug for disease that causes dangerous bone growth earns FDA approval


  • August 19, 2026

    STAT+: Experts scrutinize Huidagene’s disclosures after patient death


  • August 19, 2026

    Trust in science: A new STAT initiative


  • August 19, 2026

    Mayo Clinic taps new CIO as academic medical center doubles down on AI


  • August 19, 2026

    Providence Health Plan to close completely after Medicare Advantage deal falls through


  • August 19, 2026

    Moderna Surges After Personalized mRNA Cancer Treatment Clears Major Phase 3 Test


  • August 19, 2026

    Federal judge vacates Trump admin restrictions on ACA gender-affirming care


  • August 19, 2026

    STAT+: American Cancer Society cancels alcohol industry fundraiser


  • August 19, 2026

    STAT+: Brain organoids, kept alive more than five years, matured like human brains


  • August 19, 2026

    STAT+: Pharmalittle: We’re reading about an FDA commish nominee, mRNA cancer vaccine results, and more


  • August 19, 2026

    CVS adds JPMorgan data executive to board amid AI push


  • August 19, 2026

    Epic targets outpatient visits with new AI tool


Previous Page
1 … 3 4 5 6 7 … 54
Next Page
2026-03-30

JBIZNEWS LLC © 2026